The session I’m most looking forward to presenting at NAHRI's 2018 Revenue Integrity Symposium is “Next Generation Technologies: Practical Guidance for Success” because I really want to help demystify what appears to be misinformation, miscommunication, and perhaps just an overall lack of understanding about how CMS’ formulas for outliers and NTAP work. I also want to help clarify how what providers report today impacts payment rates two years down the road.
NAHRI’s 2018 Revenue Integrity Symposium is fast approaching, and I am very much looking forward to what’s in store—both at the conference and in the Phoenix area where I reside. As a reminder, the Revenue Integrity Symposium will be held October 16–17 at the Wigwam Resort in Litchfield Park (Phoenix), Arizona. This is NAHRI’s premier event for revenue integrity and revenue cycle networking and education.
Revenue integrity professionals wishing to earn support from program administrators to attend the 2018 Revenue Integrity Symposium may adapt the attached proposal.
I can’t think of a better way to celebrate your individual contributions to the field and the impact we will continue to make as a united front than to come together for NAHRI’s 2018 Revenue Integrity Symposiumto be held October 16–17 at the Wigwam Resort in Litchfield Park (Phoenix), Arizona.
The 2019 IPPS final rule finalizes an overhaul of the newly coined Promoting Interoperability Programs, significant reductions to reporting requirements for quality initiatives, and updates to payment rates.
CMS’ 2019 OPPS proposed rule continues the agency’s efforts to enforce site-neutral payments and reduce drug payments by introducing policies to reduce reimbursement for hospital outpatient clinic visits at off-campus, provider-based departments (PBD) and expanding last year’s payment reductions for drugs purchased under the 340B discount pricing program by nonexcepted PBDs.
